世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032669

ナルコレプシー治療薬の世界市場(2022-2026)

TechNavio

Global Narcolepsy Drugs Market 2022-2026

発刊日 2022/07/12

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000032669

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、ナルコレプシー治療薬市場を分析します。

世界のナルコレプシー治療薬市場は、予測期間中に約9.1 %のCAGRで推移し、2022年から2026年の間に16億USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。製品の上市や臨床試験の増加、成人におけるナルコレプシーの症例数の増加、ナルコレプシーの原因や治療法を解明するための研究数の増加が市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 脱力発作(カタプレキシー)を伴うナルコレプシー
      ◇ 脱力発作の(カタプレキシー)を伴わないナルコレプシー
      ◇ 二次性ナルコレプシー
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間におけるナルコレプシー治療薬市場の成長を促進する主要な理由の一つとして、ナルコレプシー治療の進歩が挙げられています。また、ナルコレプシーの非薬物療法や併用療法に対する需要の高まりは、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • ナルコレプシー治療薬の市場規模
  • ナルコレプシー治療薬の市場予測
  • ナルコレプシー治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なナルコレプシー治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Alkermes Public Ltd. Co.
    ➣ Apotex Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Avadel Pharmaceuticals plc
    ➣ Axsome Therapeutics Inc.
    ➣ BIOPROJET
    ➣ Cadila Pharmaceuticals Ltd.
    ➣ Don Valley Pharma
    ➣ Graymark Healthcare Inc.
    ➣ Jabs Biotech Pvt. Ltd.
    ➣ Jazz Pharmaceuticals Plc
    ➣ Luckys Pharma Pvt. Ltd.
    ➣ Midas Pharma GmbH
    ➣ Orbion Pharmaceuticals Pvt. Ltd.
    ➣ シオノギ製薬(Shionogi and Co. Ltd.)
    ➣ Somacare
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ XWPharma Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Narcolepsy with cataplexy - Market size and forecast 2021-2026
Exhibit 28: Chart on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
5.4 Narcolepsy without cataplexy - Market size and forecast 2021-2026
Exhibit 32: Chart on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
5.5 Secondary narcolepsy - Market size and forecast 2021-2026
Exhibit 36: Chart on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Type
Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Alkermes Public Ltd. Co.
Exhibit 89: Alkermes Public Ltd. Co. - Overview
Exhibit 90: Alkermes Public Ltd. Co. - Product / Service
Exhibit 91: Alkermes Public Ltd. Co. - Key news
Exhibit 92: Alkermes Public Ltd. Co. - Key offerings
10.4 Avadel Pharmaceuticals plc
Exhibit 93: Avadel Pharmaceuticals plc - Overview
Exhibit 94: Avadel Pharmaceuticals plc - Business segments
Exhibit 95: Avadel Pharmaceuticals plc - Key news
Exhibit 96: Avadel Pharmaceuticals plc - Key offerings
Exhibit 97: Avadel Pharmaceuticals plc - Segment focus
10.5 Axsome Therapeutics Inc.
Exhibit 98: Axsome Therapeutics Inc. - Overview
Exhibit 99: Axsome Therapeutics Inc. - Product / Service
Exhibit 100: Axsome Therapeutics Inc. - Key offerings
10.6 BIOPROJET
Exhibit 101: BIOPROJET - Overview
Exhibit 102: BIOPROJET - Product / Service
Exhibit 103: BIOPROJET - Key offerings
10.7 Jazz Pharmaceuticals Plc
Exhibit 104: Jazz Pharmaceuticals Plc - Overview
Exhibit 105: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 106: Jazz Pharmaceuticals Plc - Key news
Exhibit 107: Jazz Pharmaceuticals Plc - Key offerings
10.8 Shionogi and Co. Ltd.
Exhibit 108: Shionogi and Co. Ltd. - Overview
Exhibit 109: Shionogi and Co. Ltd. - Product / Service
Exhibit 110: Shionogi and Co. Ltd. - Key offerings
10.9 Somacare
Exhibit 111: Somacare - Overview
Exhibit 112: Somacare - Product / Service
Exhibit 113: Somacare - Key offerings
10.10 Takeda Pharmaceutical Co. Ltd.
Exhibit 114: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key offerings
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 118: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 119: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 120: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 122: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 XWPharma Ltd.
Exhibit 123: XWPharma Ltd. - Overview
Exhibit 124: XWPharma Ltd. - Product / Service
Exhibit 125: XWPharma Ltd. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Alkermes Public Ltd. Co. - Overview
Exhibits90: Alkermes Public Ltd. Co. - Product / Service
Exhibits91: Alkermes Public Ltd. Co. - Key news
Exhibits92: Alkermes Public Ltd. Co. - Key offerings
Exhibits93: Avadel Pharmaceuticals plc - Overview
Exhibits94: Avadel Pharmaceuticals plc - Business segments
Exhibits95: Avadel Pharmaceuticals plc - Key news
Exhibits96: Avadel Pharmaceuticals plc - Key offerings
Exhibits97: Avadel Pharmaceuticals plc - Segment focus
Exhibits98: Axsome Therapeutics Inc. - Overview
Exhibits99: Axsome Therapeutics Inc. - Product / Service
Exhibits100: Axsome Therapeutics Inc. - Key offerings
Exhibits101: BIOPROJET - Overview
Exhibits102: BIOPROJET - Product / Service
Exhibits103: BIOPROJET - Key offerings
Exhibits104: Jazz Pharmaceuticals Plc - Overview
Exhibits105: Jazz Pharmaceuticals Plc - Product / Service
Exhibits106: Jazz Pharmaceuticals Plc - Key news
Exhibits107: Jazz Pharmaceuticals Plc - Key offerings
Exhibits108: Shionogi and Co. Ltd. - Overview
Exhibits109: Shionogi and Co. Ltd. - Product / Service
Exhibits110: Shionogi and Co. Ltd. - Key offerings
Exhibits111: Somacare - Overview
Exhibits112: Somacare - Product / Service
Exhibits113: Somacare - Key offerings
Exhibits114: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits115: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits116: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits118: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits119: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits120: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits121: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits122: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits123: XWPharma Ltd. - Overview
Exhibits124: XWPharma Ltd. - Product / Service
Exhibits125: XWPharma Ltd. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

この商品のレポートナンバー

0000032669

TOP